Therapeutic and Economic Consequences of OTC Loratadine

Furler MD Rolnick MS Lawday KS Mak MW Einarson TR. Cost impact of switching histamine₂-receptor antagonists to nonprescription status. Ann Pharmacother 2002;36:1135–41. DOI 10.1345/aph.1A231.

Ya-Chen TS Prasad M Luce BR. The effect of social welfare on a switch of second generation antihistamines from prescription to over-the-counter status: A microeconomic analysis. Clin Ther 2002;24:701–16.

Brass E P. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001;345:810–6.

Kailash SC Bohn RL Avorn J. Policy analysis of histamine₂-receptor antagonists to over-the-counter use. Med Care 1997;35:32–48.

Andrade SE Gurwitz JH Fish LS. The effect of Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: The case of histamine₂-receptor antagonists. Med Care 1999;37:424–30.

Skoner DP. Allergic rhinitis: Definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(1 suppl):S2–8.

American College of Allergy Asthma and Immunology. New survey reveals allergies nearly twice as common as believed-afflicting more than one-third of Americans. Public Communications Inc. www.allergy.mcg.edu/news/survey.html (accessed 2002 Jun 6).

Saranow J Marcus AD. As Claritin sells over the counter, prices for competitors climbs. The Wall Street Journal 2002; December 10.

Kay GG Berman B Mockoviak SH Morris CE Reeves D Starbuck V Initial and steady state effects of diphenyhydramine and loratadine on sedation, cognition, mood and psychomotor performance. Arch Intern Med 1997;157:2350–6.

Weiler JM Bloomfield JR Woodworth GG. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo controlled trial in the Iowa driving simulator. Arch Intern Med 2000;132:354–63.

Cockburn IM Bailit HL Berndt ER Finkelstein SN. Loss of work productivity due to illness and medical treatment. J Occup Environ Med 1999;41:948–53.

Ward MM Javitz HS Smith M Whan MA. Lost income and work limitations in persons with chronic respiratory disorders. J Clin Epidemiol 2002;55:260–8.

Casale TB Blaiss MS Gelfand E Gilmore T Harvey PD Hindmarch I. First do no harm: Managing antihistamine impairment in patient with allergic rhinitis. J Aller Clin Immunol 2003;111:835–42.

Yde S Koch Ernst ME Kelley MW. Patient perceptions about drug advertising and prescription-to-nonprescription switches (letter). Am J Health Syst Pharm 2002;59:1568.

Sullivan PW Follin SL Nichol MB. Transitioning the second-generation antihistamines to over-the-counter status: A cost-effectiveness analysis. Med Care 2003, in press.

Kaufman M. FDA says it can take away drug's prescription status. The Washington Post 2002 April 26.